Literature DB >> 16325472

Membrane-lipid therapy: a new approach in molecular medicine.

Pablo V Escribá1.   

Abstract

Although most drugs bind to proteins and regulate their activity, some drugs act through a new therapeutic approach called membrane-lipid therapy and bind to lipids, thus modulating the structure of membranes. Most cellular functions are highly dependent on the lipid environment because they are controlled by proteins in or around membranes. The wide variety of cell and organelle membranes and the existence of special lipid regions (e.g. microvilli) and domains (e.g. lipid rafts) support the possibility of designing specific lipid therapies. Indeed, recent evidence suggests that lipid therapy might have potential for the treatment of cancer, cardiovascular pathologies, neurodegenerative processes, obesity, metabolic disorders, inflammation, and infectious and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325472     DOI: 10.1016/j.molmed.2005.11.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  55 in total

1.  Vitamin E prevents lipid raft modifications induced by an anti-cancer lysophospholipid and abolishes a Yap1-mediated stress response in yeast.

Authors:  Teshager Bitew; Christopher E Sveen; Belinda Heyne; Vanina Zaremberg
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Cell biology: Stability in times of stress.

Authors:  Ibolya Horváth; László Vígh
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

3.  Triacylglycerol mimetics regulate membrane interactions of glycogen branching enzyme: implications for therapy.

Authors:  Rafael Alvarez; Jesús Casas; David J López; Maitane Ibarguren; Ariadna Suari-Rivera; Silvia Terés; Francisca Guardiola-Serrano; Alexander Lossos; Xavier Busquets; Or Kakhlon; Pablo V Escribá
Journal:  J Lipid Res       Date:  2017-06-19       Impact factor: 5.922

4.  Lipids Alter Rhodopsin Function via Ligand-like and Solvent-like Interactions.

Authors:  Leslie A Salas-Estrada; Nicholas Leioatts; Tod D Romo; Alan Grossfield
Journal:  Biophys J       Date:  2018-01-23       Impact factor: 4.033

5.  The Functional Activity of the Human Serotonin 5-HT1A Receptor Is Controlled by Lipid Bilayer Composition.

Authors:  M Gertrude Gutierrez; Kylee S Mansfield; Noah Malmstadt
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

6.  Can Specific Protein-Lipid Interactions Stabilize an Active State of the Beta 2 Adrenergic Receptor?

Authors:  Chris Neale; Henry D Herce; Régis Pomès; Angel E García
Journal:  Biophys J       Date:  2015-10-20       Impact factor: 4.033

Review 7.  Lipid simulations: a perspective on lipids in action.

Authors:  Ilpo Vattulainen; Tomasz Rog
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

8.  Interactions of fatty acids with phosphatidylethanolamine membranes: X-ray diffraction and molecular dynamics studies.

Authors:  Arnau Cordomí; Jesús Prades; Juan Frau; Oliver Vögler; Sérgio S Funari; Juan J Perez; Pablo V Escribá; Francisca Barceló
Journal:  J Lipid Res       Date:  2009-11-19       Impact factor: 5.922

9.  A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.

Authors:  Ana Catarina Alves; Daniela Ribeiro; Miguel Horta; José L F C Lima; Cláudia Nunes; Salette Reis
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118

10.  In vitro assessment of NSAIDs-membrane interactions: significance for pharmacological actions.

Authors:  Cláudia Nunes; Daniela Lopes; Marina Pinheiro; Catarina Pereira-Leite; Salette Reis
Journal:  Pharm Res       Date:  2013-05-24       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.